Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease
1 clinical trials · Condition
◉ Watch Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease (NCT04685499) | Weill Medical College of Cornell University | 2021-05-03 |
Track Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease automatically
Every clearance here is in the API, with alerts when new ones post.